Achilles Therapeutics plc Quarterly Liabilities and Equity in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Achilles Therapeutics plc quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q2 2024.
Achilles Therapeutics plc Liabilities and Equity for the quarter ending June 30, 2024 was $131M, a 33.7% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$131M	-$66.7M	-33.7%	Jun 30, 2024	6-K	2024-08-14
Q4 2023	$161M	-$58.9M	-26.7%	Dec 31, 2023	6-K	2024-08-14
Q2 2023	$198M			Jun 30, 2023	6-K	2023-08-04
Q4 2022	$220M	-$96.7M	-30.5%	Dec 31, 2022	20-F	2024-04-04
Q4 2021	$317M	+$98.2M	+44.9%	Dec 31, 2021	20-F	2023-03-07
Q4 2020	$219M			Dec 31, 2020	20-F	2022-03-01

* An asterisk sign (*) next to the value indicates that the value is likely invalid.